How our AI Engines Free Drug Hunters from Granting IP Co-Ownership

Inflexible Conventional Methodology


Drug hunters create hypotheses from targets and design bioassays to test the hypotheses.

Accordingly, co-development with AI platform providers necessitates disclosure of the target, the hypothesis, and sharing of the prospective intellectual property ownership.

Keff target illustration

Exclusive Ultra-dimensional Accuracy


Instead of relying on target hypotheses, our predictive intelligence engine derives accurate equations from real-world bioassay statistics like a physicist.

As a consequence, target disclosure is no longer required. So please do not disclose your target to us!

Keff target illustration